GlassScriptPhysician profile
Phillip R Kingma
NPI 1629038419
$4,774.28
in general payments reported to CMS, 2019-2025
18 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $197 · 2021: $962 · 2022: $970 · 2023: $734 · 2024: $501 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $2,610.73 | 2019-2024 | Mild Device Kit |
| Abbott Laboratories | $1,643.49 | 2019-2025 | Proclaim, Eterna |
| Painteq LLC | $72.30 | 2023 | Painteq |
| Biodelivery Sciences International, INC. | $59.60 | 2019 | |
| Assertio Therapeutics, INC. | $58.43 | 2019 | |
| Pfizer INC. | $46.21 | 2019 | |
| Saluda Medical Americas, INC. | $40.37 | 2024 | Evoke |
| Collegium Pharmaceutical, INC. | $39.85 | 2019 | |
| Medtronic USA, INC. | $29.38 | 2019 | |
| Boston Scientific Corporation | $28.98 | 2024 | Wavewriter Alpha Prime 16 |
| Kaleo, INC. | $28.97 | 2019 | |
| Almatica Pharma LLC | $24.16 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $23.40 | 2019 | |
| Nevro Corp. | $17.65 | 2019 | |
| Medline Industries LP | $15.93 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pernix Therapeutics Holdings, INC. | $12.72 | 2019 | |
| Vertiflex, INC. | $11.18 | 2019 | |
| Mdd US Operations, LLC | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Kingma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.